Anna Vaqué, MD

Medical Drug Safety Officer & back up EUQPPV
ESTEVE Pharmaceuticals S.A.
Barcelona, Catalonia, Spain

Presentation(s):

• Poster Number-64 - ADV-502, a Novel Dual Sigma-1 Receptor Antagonist and Mu-Opioid Receptor Agonist for the Treatment of Pain: III. Phase-1 Study

  Poster Abstracts

• Poster Number-74 - CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL IN PATIENTS WITH MODERATE-TO-SEVERE PAIN FOLLOWING BUNIONECTOMY WITH OSTEOTOMY: SECONDARY ANALYSES OF A PHASE 3, RANDOMIZED, DOUBLE-BLIND, FACTORIAL, ACTIVE- AND PLACEBO-CONTROLLED TRIAL

  Poster Abstracts

• Poster Number-69 - CELECOXIB-TRAMADOL HYDROCHLORIDE CO-CRYSTAL SAFETY, TOLERABILITY, AND DIFFERENTIAL PHARMACOKINETICS: A SUMMARY OF FIVE PHASE 1 RANDOMIZED CLINICAL TRIALS

  Poster Abstracts